249 related articles for article (PubMed ID: 30074840)
1. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
[TBL] [Abstract][Full Text] [Related]
2. Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.
Gross GJ; Hsu A; Pfeiffer AW; Nithipatikom K
J Mol Cell Cardiol; 2013 Jun; 59():20-9. PubMed ID: 23419451
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.
Gross GJ; Baker JE; Hsu A; Wu HE; Falck JR; Nithipatikom K
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2201-7. PubMed ID: 20400686
[TBL] [Abstract][Full Text] [Related]
5. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Gross GJ; Gauthier KM; Moore J; Falck JR; Hammock BD; Campbell WB; Nithipatikom K
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2838-44. PubMed ID: 18441205
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
[TBL] [Abstract][Full Text] [Related]
7. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
[TBL] [Abstract][Full Text] [Related]
8. Roxadustat Markedly Reduces Myocardial Ischemia Reperfusion Injury in Mice.
Deguchi H; Ikeda M; Ide T; Tadokoro T; Ikeda S; Okabe K; Ishikita A; Saku K; Matsushima S; Tsutsui H
Circ J; 2020 May; 84(6):1028-1033. PubMed ID: 32213720
[TBL] [Abstract][Full Text] [Related]
9. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
10. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
[TBL] [Abstract][Full Text] [Related]
11. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
Adluri RS; Thirunavukkarasu M; Dunna NR; Zhan L; Oriowo B; Takeda K; Sanchez JA; Otani H; Maulik G; Fong GH; Maulik N
Antioxid Redox Signal; 2011 Oct; 15(7):1789-97. PubMed ID: 21083501
[TBL] [Abstract][Full Text] [Related]
12. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
Alánová P; Husková Z; Kopkan L; Sporková A; Jíchová Š; Neckář J; Imig JD; Klevstig M; Kolář F; Rami Reddy N; Falck JR; Sadowski J; Nishiyama A; Kramer HJ; Melenovský V; Červenková L; Kujal P; Vernerová Z; Červenka L
Vascul Pharmacol; 2015 Oct; 73():45-56. PubMed ID: 26304700
[TBL] [Abstract][Full Text] [Related]
13. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
[TBL] [Abstract][Full Text] [Related]
14. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
[TBL] [Abstract][Full Text] [Related]
15. Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts.
Gross GJ; Baker JE; Moore J; Falck JR; Nithipatikom K
Cardiovasc Drugs Ther; 2011 Dec; 25(6):517-22. PubMed ID: 21786213
[TBL] [Abstract][Full Text] [Related]
16. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.
Hyvärinen J; Hassinen IE; Sormunen R; Mäki JM; Kivirikko KI; Koivunen P; Myllyharju J
J Biol Chem; 2010 Apr; 285(18):13646-57. PubMed ID: 20185832
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats.
Mao X; Wang T; Liu Y; Irwin MG; Ou JS; Liao XL; Gao X; Xu Y; Ng KF; Vanhoutte PM; Xia Z
PLoS One; 2013; 8(7):e68949. PubMed ID: 23874823
[TBL] [Abstract][Full Text] [Related]
18. Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway.
Zhang P; Wang J; Wang X; Wang L; Xu S; Gong P
J Cardiovasc Transl Res; 2024 Apr; 17(2):376-387. PubMed ID: 37580643
[TBL] [Abstract][Full Text] [Related]
19. Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.
Chu HX; Jones NM
Neurochem Res; 2016 Mar; 41(3):515-22. PubMed ID: 26108712
[TBL] [Abstract][Full Text] [Related]
20. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
